Turner S T, Rebbeck T R, Sing C F
Division of Hypertension, Mayo Clinic, Rochester, Minn.
Hypertension. 1992 Dec;20(6):841-50. doi: 10.1161/01.hyp.20.6.841.
The objectives of the present study were to determine whether sodium-lithium countertransport contributes to predicting the probability of having hypertension and to determine whether it does so after other predictor traits have been considered. We used logistic regression to model the relation between sodium-lithium countertransport and the probability of having hypertension, estimated by the prevalence of hypertension among 172 men and 252 women, aged 47-89 years, from the Caucasian population of Rochester, Minn. When sodium-lithium countertransport was the only predictor trait considered, it made a statistically significant contribution to prediction both in men (model chi(2)1df = 20.50, p < 0.001) and in women (model chi(2)1df = 16.69, p < 0.001). For each standard deviation increase in sodium-lithium counter-transport, the expected odds of having hypertension increased 2.25 times in men (95% confidence interval [CI], 1.44-3.51) and 1.77 times in women (95% CI, 1.32-2.37). When sodium-lithium countertransport was not considered, the other traits identified as predictors were age, body mass index, and plasma apolipoprotein CII and CII squared; plasma apolipoprotein AI was an additional predictor in women but not in men. When sodium-lithium countertransport was added to models that included the other predictors, it improved prediction both in men (increase in model chi(2)1df = 12.29, p < 0.001) and in women (increase in model chi(2)1df = 4.86, p < 0.027). Based on these complete models, when the other predictors remained at their mean values, each standard deviation increase in sodium-lithium countertransport increased the expected odds of having hypertension 2.06 times in men (95% CI, 1.31-3.22) and 1.48 times in women (95% CI, 1.04-2.21). These results establish that sodium-lithium countertransport provides information that is helpful in predicting the probability of having hypertension and is not reflected in other identified predictor traits.
本研究的目的是确定钠-锂逆向转运是否有助于预测患高血压的概率,以及在考虑了其他预测特征后它是否仍有此作用。我们使用逻辑回归来建立钠-锂逆向转运与患高血压概率之间的关系模型,该概率通过明尼苏达州罗切斯特市白种人群中172名男性和252名年龄在47 - 89岁女性的高血压患病率来估计。当仅考虑钠-锂逆向转运这一预测特征时,它对男性(模型卡方检验自由度为1时,卡方值 = 20.50,p < 0.001)和女性(模型卡方检验自由度为1时,卡方值 = 16.69,p < 0.001)的预测均有显著统计学贡献。钠-锂逆向转运每增加一个标准差,男性患高血压的预期比值增加2.25倍(95%置信区间[CI],1.44 - 3.51),女性增加1.77倍(95% CI,1.32 - 2.37)。当不考虑钠-锂逆向转运时,其他被确定为预测因子的特征有年龄、体重指数、血浆载脂蛋白CII及其平方;血浆载脂蛋白AI在女性中是额外的预测因子,在男性中则不是。当将钠-锂逆向转运添加到包含其他预测因子的模型中时,它在男性(模型卡方检验自由度为1时增加量 = 12.29,p < 0.001)和女性(模型卡方检验自由度为1时增加量 = 4.86,p < 0.027)中均改善了预测效果。基于这些完整模型,当其他预测因子保持在其均值时,钠-锂逆向转运每增加一个标准差,男性患高血压的预期比值增加2.06倍(95% CI,1.31 - 3.22),女性增加1.48倍(95% CI,1.04 - 2.21)。这些结果表明,钠-锂逆向转运提供了有助于预测患高血压概率的信息,且该信息未在其他已确定的预测特征中体现。